Chemed director exercises options for 4,629 shares
The transaction also includes 4,270 shares delivered or withheld for exercise-price or tax-liability payment and a reported resulting position of 22,089 stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemed Corp. vice president and director Thomas C. Hutton exercised stock options to acquire 4,629 shares of capital stock on September 28, 2026, at an exercise price of $445.35 per share. He also reported 4,270 shares delivered or withheld for payment of exercise price or tax liability; his reported resulting position was 22,089 stock options. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy with tandem tax withholding) F2 | 4,629 | $445.35 | $2.06M |
| Exercise | Capital Stock | 4,629 | $445.35 | $2.06M |
| Tax Withholding | Capital Stock F1 | 4,270 | $506.65 | $2.16M |
Footnotes (2)
- F1. Payment of purchase price and tax obligation on stock option exercise.
- F2. Vesting in three equal annual installments commencing 10/28/2022.
Key Figures
Key Terms
tandem tax withholding financial
vesting financial
tax obligation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CHE vice president Thomas C. Hutton report on September 28, 2026?
What were the vesting and expiration terms of Thomas C. Hutton’s CHE stock option?
AI-generated analysis. How Rhea-AI works. Not financial advice.